Home

Investor Relations

Company Profile

Corporate Governance

Investor Fact Sheet

Stock Information

Analysts Coverage

Email Alerts

Press Room

Press Releases

Presentations & Recent Events

EnteroMedics Backgrounder

Request Media Kit

EnteroMedics FAQ

Abstracts and Articles

Glossary

Contact Information

SEC Filings

Investor FAQs

Shareholder Briefcase

 

 

Press Room

Welcome to the EnteroMedics press room. This resource is intended for media professionals and investors who would like to learn more about EnteroMedics and VBLOCTM vagal blocking therapy. For press inquiries, please contact Greg S. Lea , Senior Vice President and Chief Financial Officer, EnteroMedics Inc., 651.789.2860, ir@enteromedics.com.


 

 

Home | What is VBLOCTM Therapy? | Why VBLOCTM Therapy? | Bariatric Weight Loss Surgery
Surgical Candidates | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised November 2007.